BioTek continues to set the standard in microplate instrumentation

Published on August 15, 2014 at 10:36 AM · No Comments

BioTek continues to set the standard in microplate instrumentation by designing practical functionality, user-friendly software, and affordable modularity as seen in the new Synergy™ HTX Multi-Mode Microplate Reader. This new system is offered as an entry-level multi-mode reader to automate UV-Vis absorbance, fluorescence, luminescence and AlphaScreen®/AlphaLISA® assays in 6- to 384-well microplates in 2 µL samples with BioTek’s Take3 Micro-Volume plates.

The unique dual-optics design results in superior filter based top and bottom fluorescence, luminescence and monochromator based absorbance measurements for maximum applications versatility. Synergy HTX’s modularity allows upgrading over time and BioTek’s powerful Gen5™ Software controls all functionality while providing data analysis for many applications within one powerful yet intuitive package.

Synergy HTX has linear and orbital shaking and 4-Zone™ incubation to 50 °C with condensation control to minimize plate lid condensation. These features, plus an available dual reagent dispenser, make Synergy HTX an ideal platform for biochemical and cell-based applications like nucleic acid quantification, cell growth and toxicity assays, kinetic ELISA and inject/read assays. Workflows can be further automated with the BioStack™ Microplate Stacker or third-party automation.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. These technologies are used to aid life science research, facilitate drug discovery, provide rapid and cost-effective analysis, and enable sensitive, accurate quantification of molecules across diverse applications. BioTek espouses a “Think Possible” approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations. As such, they are often honored for local accomplishments and technological innovations, including Best Places to Work in Vermont, Frost & Sullivan North American New Product Innovation Award for Workflow Solutions in Life Sciences, SelectScience’s Drug Discovery Product of the Year – Scientists' Choice Award, and a Silver Edison Award for the Cytation Cell Imaging Multi-Mode Reader.

AlphaScreen®/AlphaLISA® are registered trademarks of Perkin Elmer, Inc.

Posted in: Device / Technology News

Tags: ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Study explains why people with disrupted circadian rhythms can be more susceptible to cancer